Effect of aclidinium bromide on cough and sputum symptoms in moderate-to-severe COPD in three phase III trials. (2016)

First Author: McGarvey L

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/bmjresp-2016-000148

PubMed Identifier: 28074135

Publication URI: http://europepmc.org/abstract/MED/28074135

Type: Journal Article/Review

Volume: 3

Parent Publication: BMJ open respiratory research

Issue: 1

ISSN: 2052-4439